ELF vs REGN · P/E 60, rev $332.6M vs P/E 14, rev $14.34B
ELF Beauty Inc (ELF) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
ELF Beauty Inc (ELF) is a household & personal products company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ELF revenue for 2025-03-31 was $332.6M. Net income was $28.3M. Revenue was down 6.4% from 2024-12-31 to 2025-03-31. ELF currently screens at market cap $6.55B and trailing P/E 60.1.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ELF currently screens at market cap $6.55B and trailing P/E 60.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ELF and REGN stock pages for the full models.
Not investment advice.